In the central nervous system (CNS) peroxisomes are current in all cell varieties, particularly neurons, oligodendrocytes, astrocytes, microglia, and endothelial cells. Brain peroxisomes are smaller in measurement in contrast to peroxisomes from different tissues and are due to this fact referred to as microperoxisomes. We have established a purification process to isolate extremely purified peroxisomes from the central nervous system which might be nicely separated from the endoplasmic reticulum and mitochondria and are free of myelin contamination.
The main issue in purification of mind peroxisomes in contrast to peroxisomes from liver or kidney is the presence of massive quantities of myelin in the CNS, which leads to contamination of the subcellular fractions. Hence, the essential step of the isolation process is the elimination of myelin by the use of a sucrose gradient, since with out the elimination of myelin no vital enrichment of purified peroxisomes may be achieved. Another issue is that in mind tissue the abundance of peroxisomes decreases considerably throughout postnatal improvement. We present a detailed protocol for the isolation of peroxisomes from mouse central nervous system in addition to a protocol for the isolation of peroxisomes from the liver and kidney utilizing a steady Nycodenz gradient.
Isolation of Plasmodium berghei ookinetes in tradition utilizing Nycodenz density gradient columns and magnetic isolation.
BACKGROUND: Large scale in vitro manufacturing of the mosquito levels of malaria parasites stays elusive, with solely restricted success for full sporogonic improvement and just one report of improvement by to infective sporozoites. The preliminary step on this course of is the manufacturing, in vitro, of ookinetes from gametocytaemic blood. Methods for isolation of these ookinetes from blood cells have been described; nevertheless, as well as to yield typically being low, processing time and potential for contamination by erythrocytes stay excessive.
METHODS: This research compares two procedures for retaining mature ookinetes from blood stage cultures, while eradicating crimson blood cells and different contaminants prior to additional tradition of the parasite. The nicely established methodology of isolation on Nycodenz cushions is in contrast with a novel methodology using the innate magnetic properties of the haem pigment crystals present in the cytoplasm of ookinetes. RESULTS: Yield and viability of ookinetes had been comparable with each isolation strategies.
However, in our arms magnetic isolation produced a cleaner ookinete preparation far more rapidly. Moreover, lowering the stream charge by the magnetic column may additional improve the yield. CONCLUSION: We suggest the enrichment of an ookinete preparation prior to additional tradition being carried out utilizing the magnetic properties of Plasmodium berghei ookinetes in its place to their density. The former approach is quicker, removes extra erythrocytes, however day-to-day prices are larger.
Efficient purification of neonatal porcine gonocytes with Nycodenz and differential plating.
Gonocytes are the solely sort of germ cells current in the postnatal testis and give rise to spermatogonial stem cells. Purification of gonocytes has necessary implications for the research and manipulation of these cells and could present insights for the ongoing investigation of the male germline stem cells. To receive a pure inhabitants of gonocytes from piglet testis cells, a wide selection of Nycodenz concentrations had been investigated for density gradient centrifugation.
We additionally examined differential plating of testis cells for varied tradition durations with completely different extracellular matrix (ECM) parts (fibronectin, poly-d-lysine, poly-L-lysine, laminin and collagen Types I and IV). Gonocytes had been extremely enriched in pellets of testis cells after utilizing 17% Nycodenz centrifugation to a purity of 81±9%.
After culturing testis cells on plates precoated with completely different ECM parts for 120 min, the proportion of gonocytes elevated amongst non-adherent cells (suspended in the medium), with fibronectin or poly-D-lysine leading to the best (up to 85%) and laminin in the lowest (54%) gonocyte proportion. Combining the most promising ECM coatings (fibronectin and poly-d-lysine) and additional extension of their tradition length to 240 min didn’t enhance ultimate gonocyte purity.
However, centrifugation with 17% Nycodenz adopted by differential plating with fibronectin and poly-d-lysine coating additional purified gonocytes amongst the collected cells to >90%. These outcomes present a easy, fast and environment friendly strategy for acquiring extremely enriched populations of piglet gonocytes to be used in the research and manipulation of these germline stem cells.
Separation and dedication of nycodenz and its impurities by capillary electrophoresis
Separation and dedication of nycodenz (a new radiography reagent) and its impurities by capillary electrophoresis was investigated. Since the analytes had been polyols, Na2B4O7-H3BO3 was chosen as the buffer system. The analytes had been negatively charged by complexing with borate. Then cetyltrimethylammonium bromide was used to reverse electroosmotic mobility so as to shorten the evaluation time. 2-Propanol was added to optimize the separation additional. Acceptable outcomes of linearity, precision of corrected peak space and migration time had been obtained. The RSD(n = 6) of corrected peak space and migration time had been 0.73% and 1.4% respectively. The outcomes obtained by CE had been immediately in contrast to these obtained by excessive efficiency liquid chromatography.
Purification of mouse primordial germ cells by Nycodenz.
Primordial germ cells are necessary cells for the research of germ cell lineage. It has proved troublesome to receive extremely purified primordial germ cells for preparation of a particular antibody. In the current research, a new methodology for purifying mouse primordial germ cells was developed utilizing a Nycodenz gradient. Furthermore, the polyclonal anti-mouse primordial germ cells IgG derived from mouse primordial germ cells was ready. As this IgG reacted solely with primordial germ cells obtained at day 12.5 after mating, this antibody appeared to acknowledge the stage-specific antigen of primordial germ cells.
One motive that a steady primordial germ cell marker has not been obtained is as a result of the purity of the primordial germ cells used has been too low to put together the antibody. This new methodology represents a vital enchancment in the purification of primordial germ cells; it’s less complicated than earlier strategies, and produced mouse primordial germ cells with a purity of greater than 95%.
Recombinant Neurospora crassa Nitrogen metabolic regulation protein 1 (nmr-1) |
|||
| MBS1119341-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1230 |
Recombinant Neurospora crassa Nitrogen metabolic regulation protein 1 (nmr-1) |
|||
| MBS1119341-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1310 |
3-Mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-ol-d4(Spiromesifen Metabolite M01) |
|||
| M225647 | Toronto Research Chemicals | 100mg | EUR 11200 |
3-Mesityl-2-oxo-1-oxaspiro[4.4]non-3-en-4-ol-d4(Spiromesifen Metabolite M01) |
|||
| TRC-M225647-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
Toxic Cabinet |
|||
| 47-TXC100 | Lab Expo | 1 Each | Ask for price |
|
Description: Toxic Cabinet is a dual walled manual fire resistance cabinet with 38 mm of insulating air space. Doors are reinforced with a three point latch and manual lock for security. Features two adjustable shelves to accommodate storage for different containers with 2 inches vents integrated with flame arresters. Equipped with spill catcher shelves for preventing incidental drips. Inner and outer lead free powder coating provides durability and chemical resistance preventing corrosion and humidity. |
|||
Toxic Cabinet |
|||
| 47-TXC200 | Lab Expo | 1 Each | Ask for price |
|
Description: Toxic Cabinet is a dual walled manual combustion cabinet with 38 mm of insulating air space. Doors are reinforced with a three point latch and manual lock for security. Features one adjustable shelf to accommodate storage for different containers with 2 inches vents integrated with flame arresters. Equipped with spill catcher shelves for preventing incidental drips. Inner and outer lead free powder coating provides durability and chemical resistance preventing corrosion and humidity. |
|||
Purified Recombinant Anthrax Protective Antigen (83 kD) (Non toxic), vaccine grade |
|||
| AV-9140-100 | Alpha Diagnostics | 100 ug | EUR 781.2 |
Purified Recombinant Anthrax Protective Antigen (83 kD) (Non toxic), vaccine grade |
|||
| AV-9140-1000 | Alpha Diagnostics | 1 mg | EUR 2910 |
Toxic Shock Toxin Antibody |
|||
| GWB-5D4919 | GenWay Biotech | 1 ml | Ask for price |
Toxic Substance Mix - 1ML |
|||
| 8270-AF-TSM | Scientific Laboratory Supplies | 1ML | EUR 213.3 |
RTA | Ricin toxic A chain |
|||
| AS17-4143 | Agrisera AB | 50 µl | EUR 302 |
RTB | Ricin toxic B chain |
|||
| AS17-4144 | Agrisera AB | 50 µl | EUR 302 |
GNF179 (Metabolite) |
|||
| HY-15980 | MedChemExpress | 50mg | EUR 2539.2 |
GNF179 Metabolite |
|||
| MBS3845465-100mg | MyBiosource | 100mg | EUR 4500 |
GNF179 Metabolite |
|||
| MBS3845465-10mg | MyBiosource | 10mg | EUR 810 |
GNF179 Metabolite |
|||
| MBS3845465-50mg | MyBiosource | 50mg | EUR 2290 |
GNF179 Metabolite |
|||
| MBS3845465-5mg | MyBiosource | 5mg | EUR 495 |
GNF179 Metabolite |
|||
| MBS3845465-5x100mg | MyBiosource | 5x100mg | EUR 20235 |
GNF179 (Metabolite) |
|||
| T11445-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: GNF179 (Metabolite) |
|||
GNF179 (Metabolite) |
|||
| T11445-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: GNF179 (Metabolite) |
|||
GNF179 (Metabolite) |
|||
| T11445-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: GNF179 (Metabolite) |
|||
GNF179 (Metabolite) |
|||
| T11445-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: GNF179 (Metabolite) |
|||
GNF179 (Metabolite) |
|||
| T11445-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: GNF179 (Metabolite) |
|||
100x100mm Toxic GHS sheet - EACH |
|||
| GHSC100TO | Scientific Laboratory Supplies | EACH | EUR 23.52 |
AR-13324 M1 metabolite |
|||
| MBS5752710-10mg | MyBiosource | 10mg | EUR 535 |
AR-13324 M1 metabolite |
|||
| MBS5752710-50mg | MyBiosource | 50mg | EUR 1560 |
AR-13324 M1 metabolite |
|||
| MBS5752710-5mg | MyBiosource | 5mg | EUR 320 |
AR-13324 M1 metabolite |
|||
| MBS5752710-5x50mg | MyBiosource | 5x50mg | EUR 6870 |
AR-13324 M1 metabolite |
|||
| T10358L-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: AR-13324 M1 metabolite |
|||
AR-13324 M1 metabolite |
|||
| T10358L-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: AR-13324 M1 metabolite |
|||
AR-13324 M1 metabolite |
|||
| T10358L-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: AR-13324 M1 metabolite |
|||
AR-13324 M1 metabolite |
|||
| T10358L-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: AR-13324 M1 metabolite |
|||
AR-13324 M1 metabolite |
|||
| T10358L-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: AR-13324 M1 metabolite |
|||
Avacopan metabolite M1 |
|||
| A264660 | Toronto Research Chemicals | 25mg | EUR 11200 |
|
Description: 1346623-14-0 |
|||
Avanafil metabolite M4 |
|||
| 574222 | MedKoo Biosciences | 1.0mg | EUR 770 |
5-Fluoro ADB Metabolite 7 |
|||
| F587258 | Toronto Research Chemicals | 250mg | EUR 3000 |
5-Fluoro ADB Metabolite 2 |
|||
| F587263 | Toronto Research Chemicals | 500mg | EUR 7600 |
5-Fluoro AMB Metabolite 2 |
|||
| F588295 | Toronto Research Chemicals | 100mg | EUR 7600 |
|
Description: 1890250-14-2 |
|||
Avanafil metabolite M4 |
|||
| MBS5798134-1mg | MyBiosource | 1(mg | EUR 870 |
Avanafil metabolite M4 |
|||
| MBS5798134-5x1mg | MyBiosource | 5x1(mg | EUR 3765 |
Avanafil metabolite M4 |
|||
| T37181-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Avanafil metabolite M4 |
|||
Avanafil metabolite M4 |
|||
| T37181-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Avanafil metabolite M4 |
|||
Avanafil metabolite M4 |
|||
| T37181-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Avanafil metabolite M4 |
|||
Avanafil metabolite M4 |
|||
| T37181-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Avanafil metabolite M4 |
|||
Avanafil metabolite M4 |
|||
| T37181-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Avanafil metabolite M4 |
|||
5-Fluoro ADB Metabolite 7 |
|||
| TRC-F587258-250MG | Toronto Research Chemicals | 250 mg | Ask for price |
Avacopan metabolite M1 |
|||
| TRC-A264660-25MG | Toronto Research Chemicals | 25 mg | Ask for price |
5-Fluoro AMB Metabolite 2 |
|||
| TRC-F588295-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
5-Fluoro ADB Metabolite 2 |
|||
| TRC-F587263-500MG | Toronto Research Chemicals | 500 mg | Ask for price |
Alectinib M4 metabolite |
|||
| A521150 | Toronto Research Chemicals | 10mg | EUR 362 |
|
Description: 1256585-04-2 |
|||
Avanafil metabolite M16 |
|||
| 574225 | MedKoo Biosciences | 1.0mg | EUR 705 |
Docetaxel Metabolite M4 |
|||
| D494410 | Toronto Research Chemicals | 0.5mg | EUR 2082 |
|
Description: 157067-34-0 |
|||
Prasugrel metabolite |
|||
| MBS132419-100mg | MyBiosource | 100mg | EUR 1065 |
Prasugrel metabolite |
|||
| MBS132419-500mg | MyBiosource | 500mg | EUR 2775 |
Lopinavir Metabolite M-1 |
|||
| HY-136703 | MedChemExpress | Get quote | Ask for price |
|
Description: Lopinavir Metabolite M-1, an active metabolite of Lopinavir, inhibits HIV protease with a Ki of 0.7 pM. Lopinavir Metabolite M-1 has antiviral activities in vitro[1][2]. |
|||
Ritonavir metabolite |
|||
| HY-G0009 | MedChemExpress | 50mg | EUR 1383.6 |
Niraparib metabolite M1 |
|||
| HY-G0023 | MedChemExpress | 5mg | EUR 968.4 |
Dasatinib metabolite M6 |
|||
| HY-131669 | MedChemExpress | 10 mg | EUR 1677.52 |
|
Description: Dasatinib metabolite M6 (Dasatinib carboxylic acid) is an oxidative metabolite of Dasatinib (HY-10181). Dasatinib is a potent and orally active dual Bcr-Abl and Src family tyrosine kinase inhibitor[1]. |
|||
Amitraz metabolite-d3 |
|||
| HY-146963S | MedChemExpress | 1mg | Ask for price |
|
Description: Amitraz metabolite-d3 is the deuterium labeled Amitraz metabolite. |
|||
Lopinavir Metabolite M-1 |
|||
| L469485 | Toronto Research Chemicals | 1mg | EUR 922 |
|
Description: 192725-39-6 |
|||
Lopinavir Metabolite M-3/M-4 |
|||
| L469490 | Toronto Research Chemicals | 1mg | EUR 496 |
|
Description: 357275-54-8 |
|||
Niraparib metabolite M1 |
|||
| MBS5753577-10mg | MyBiosource | 10mg | EUR 990 |
Niraparib metabolite M1 |
|||
| MBS5753577-5x10mg | MyBiosource | 5x10mg | EUR 4300 |
Lopinavir Metabolite M-1 |
|||
| MBS6057374-1mg | MyBiosource | 1(mg | EUR 715 |
Lopinavir Metabolite M-1 |
|||
| MBS6057374-5x1mg | MyBiosource | 5x1mg | EUR 3075 |
Lopinavir Metabolite M-3/M-4 |
|||
| MBS6030722-1mg | MyBiosource | 1(mg | EUR 790 |
Lopinavir Metabolite M-3/M-4 |
|||
| MBS6030722-5x1mg | MyBiosource | 5x1mg | EUR 3395 |
Docetaxel Metabolite M4 |
|||
| MBS6046015-05mg | MyBiosource | 0.5(mg | EUR 1860 |
Docetaxel Metabolite M4 |
|||
| MBS6046015-5x05mg | MyBiosource | 5x0.5mg | EUR 8220 |
Lopinavir Metabolite M-1 |
|||
| MBS5799842-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Dasatinib metabolite M6 |
|||
| MBS5798492-10mg | MyBiosource | 10mg | EUR 475 |
Dasatinib metabolite M6 |
|||
| MBS5798492-25mg | MyBiosource | 25(mg | EUR 835 |
Dasatinib metabolite M6 |
|||
| MBS5798492-5mg | MyBiosource | 5(mg | EUR 315 |
Avanafil metabolite M16 |
|||
| MBS5798133-1mg | MyBiosource | 1(mg | EUR 780 |
Avanafil metabolite M16 |
|||
| MBS5798133-5x1mg | MyBiosource | 5x1(mg | EUR 3365 |
Nilotinib Metabolite 2 |
|||
| N465330 | Toronto Research Chemicals | 25mg | EUR 4500 |
|
Description: 1807606-80-9 |
|||
Nilotinib Metabolite 3 |
|||
| N465335 | Toronto Research Chemicals | 25mg | EUR 9200 |
|
Description: 1807607-72-2 |
|||
Nilotinib Metabolite 4 |
|||
| N465340 | Toronto Research Chemicals | 25mg | EUR 12800 |
|
Description: 1807608-52-1 |
|||
Avanafil metabolite M16 |
|||
| T37180-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Avanafil metabolite M16 |
|||
Avanafil metabolite M16 |
|||
| T37180-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Avanafil metabolite M16 |
|||
Avanafil metabolite M16 |
|||
| T37180-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Avanafil metabolite M16 |
|||
Avanafil metabolite M16 |
|||
| T37180-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Avanafil metabolite M16 |
|||
Avanafil metabolite M16 |
|||
| T37180-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Avanafil metabolite M16 |
|||
Dasatinib metabolite M6 |
|||
| T37645-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Dasatinib metabolite M6 |
|||
Dasatinib metabolite M6 |
|||
| T37645-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Dasatinib metabolite M6 |
|||
Dasatinib metabolite M6 |
|||
| T37645-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Dasatinib metabolite M6 |
|||
Dasatinib metabolite M6 |
|||
| T37645-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Dasatinib metabolite M6 |
|||
Dasatinib metabolite M6 |
|||
| T37645-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Dasatinib metabolite M6 |
|||
Niraparib metabolite M1 |
|||
| T12229-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Niraparib metabolite M1 |
|||
Niraparib metabolite M1 |
|||
| T12229-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Niraparib metabolite M1 |
|||
Niraparib metabolite M1 |
|||
| T12229-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Niraparib metabolite M1 |
|||
Niraparib metabolite M1 |
|||
| T12229-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Niraparib metabolite M1 |
|||
Niraparib metabolite M1 |
|||
| T12229-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Niraparib metabolite M1 |
|||
Ritonavir metabolite |
|||
| T12735-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Ritonavir metabolite |
|||
Ritonavir metabolite |
|||
| T12735-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Ritonavir metabolite |
|||
Ritonavir metabolite |
|||
| T12735-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Ritonavir metabolite |
|||
Ritonavir metabolite |
|||
| T12735-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Ritonavir metabolite |
|||
Ritonavir metabolite |
|||
| T12735-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Ritonavir metabolite |
|||
Lopinavir Metabolite M-1 |
|||
| T39345-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Lopinavir Metabolite M-1 |
|||
Lopinavir Metabolite M-1 |
|||
| T39345-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Lopinavir Metabolite M-1 |
|||
Lopinavir Metabolite M-1 |
|||
| T39345-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Lopinavir Metabolite M-1 |
|||
Lopinavir Metabolite M-1 |
|||
| T39345-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Lopinavir Metabolite M-1 |
|||
Lopinavir Metabolite M-1 |
|||
| T39345-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Lopinavir Metabolite M-1 |
|||
Lopinavir Metabolite M-1 |
|||
| TRC-L469485-5MG | Toronto Research Chemicals | 5 mg | Ask for price |
Nilotinib Metabolite 2 |
|||
| TRC-N465330-25MG | Toronto Research Chemicals | 25 mg | Ask for price |
Nilotinib Metabolite 4 |
|||
| TRC-N465340-25MG | Toronto Research Chemicals | 25 mg | Ask for price |
Lopinavir Metabolite M-1 |
|||
| TRC-L469485-1MG | Toronto Research Chemicals | 1 mg | Ask for price |
Docetaxel Metabolite M4 |
|||
| TRC-D494410-1MG | Toronto Research Chemicals | 1 mg | Ask for price |
Nilotinib Metabolite 3 |
|||
| TRC-N465335-25MG | Toronto Research Chemicals | 25 mg | Ask for price |
Lopinavir Metabolite M-3/M-4 |
|||
| TRC-L469490-1MG | Toronto Research Chemicals | 1 mg | Ask for price |
Docetaxel Metabolite M4 |
|||
| TRC-D494410-0.5MG | Toronto Research Chemicals | 0.5 mg | Ask for price |
Alectinib M4 metabolite |
|||
| TRC-A521150-2.5MG | Toronto Research Chemicals | 2.5 mg | Ask for price |
Alectinib M4 metabolite |
|||
| TRC-A521150-10MG | Toronto Research Chemicals | 10 mg | Ask for price |
Alectinib M4 metabolite |
|||
| TRC-A521150-5MG | Toronto Research Chemicals | 5 mg | Ask for price |
Toxic Shock Syndrome Toxin (TSST) (AP) |
|||
| MBS6503147-01mL | MyBiosource | 0.1mL | EUR 920 |
Toxic Shock Syndrome Toxin (TSST) (AP) |
|||
| MBS6503147-5x01mL | MyBiosource | 5x0.1mL | EUR 3995 |
Toxic Shock Syndrome Toxin (TSST) (PE) |
|||
| MBS6503157-01mL | MyBiosource | 0.1mL | EUR 920 |
Toxic Shock Syndrome Toxin (TSST) (PE) |
|||
| MBS6503157-5x01mL | MyBiosource | 5x0.1mL | EUR 3995 |
Toxic Shock Syndrome Toxin (TSST) (APC) |
|||
| MBS6503148-01mL | MyBiosource | 0.1mL | EUR 920 |
Toxic Shock Syndrome Toxin (TSST) (APC) |
|||
| MBS6503148-5x01mL | MyBiosource | 5x0.1mL | EUR 3995 |
Toxic Shock Syndrome Toxin (TSST) (HRP) |
|||
| MBS6503151-01mL | MyBiosource | 0.1mL | EUR 920 |
Toxic Shock Syndrome Toxin (TSST) (HRP) |
|||
| MBS6503151-5x01mL | MyBiosource | 5x0.1mL | EUR 3995 |
Alectinib Metabolite M1b |
|||
| A521154 | Toronto Research Chemicals | 100mg | EUR 4500 |
Ticagrelor metabolite M5 |
|||
| 573251 | MedKoo Biosciences | 10.0mg | EUR 330 |
AB-FUBINACA Metabolite 3 |
|||
| A112628 | Toronto Research Chemicals | 100mg | EUR 3000 |
|
Description: 1877243-60-1 |
|||
AB-CHMINACA metabolite M2 |
|||
| A105995 | Toronto Research Chemicals | 25mg | EUR 1800 |
|
Description: 1185887-51-7 |
|||
AB-CHMINACA Metabolite M4 |
|||
| A106030 | Toronto Research Chemicals | 100mg | EUR 804 |
|
Description: 1271630-11-5 |
|||
Boceprevir Metabolite M4 |
|||
| B674520 | Toronto Research Chemicals | 0.5mg | EUR 1068 |
|
Description: 816444-90-3 |
|||
rac D 617 (Verapamil Metabolite) |
|||
| D100050 | Toronto Research Chemicals | 10mg | EUR 150 |
|
Description: 34245-14-2 |
|||
Lurasidone Metabolite 14283 D8 |
|||
| HY-G0001S | MedChemExpress | 50mg | EUR 9976.8 |
Lurasidone metabolite 14326 |
|||
| HY-G0002 | MedChemExpress | 10mg | EUR 3117.6 |
Lurasidone Metabolite 14326 D8 |
|||
| HY-G0002S | MedChemExpress | 50mg | EUR 9976.8 |
Cinacalcet metabolite M4 |
|||
| HY-135601 | MedChemExpress | 5 mg | EUR 103.9 |
|
Description: Cinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease[1][2]. |
|||
Ramelteon metabolite M-II |
|||
| HY-103005 | MedChemExpress | Get quote | Ask for price |
|
Description: Ramelteon metabolite M-II is the major metabolite of Ramelteon, with IC50s of 208 pM, 1470 pM for human melatonin receptors (MT1 or MT2). Ramelteon is a selective melatonin agonist. |
|||
Fenamidone Metabolite |
|||
| F245403 | Toronto Research Chemicals | 25mg | EUR 87 |
|
Description: 332855-88-6 |
|||
Cocaine Metabolite ELISA |
|||
| E22-HC9067 | EnoGene | 96T | EUR 495 |
Sonidegib metabolite M48 |
|||
| HY-117229 | MedChemExpress | Get quote | Ask for price |
|
Description: Sonidegib metabolite M48 is the main circulating metabolite of Sonidegib. Sonidegib is a hedgehog pathway inhibitor. M48 showed a much longer Tmax (60 h) than Sonidegib[1]. |
|||
M9 Metabolite of Eliglustat |
|||
| M760950 | Toronto Research Chemicals | 25mg | EUR 9500 |
Ramelteon metabolite M-II |
|||
| MBS3844373-10mg | MyBiosource | 10mg | EUR 1905 |
Ramelteon metabolite M-II |
|||
| MBS3844373-1mg | MyBiosource | 1mg | EUR 430 |
Ramelteon metabolite M-II |
|||
| MBS3844373-5mg | MyBiosource | 5mg | EUR 1165 |
Ramelteon metabolite M-II |
|||
| MBS3844373-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
Ticagrelor metabolite M5 |
|||
| MBS5756624-10mg | MyBiosource | 10mg | EUR 290 |
Ticagrelor metabolite M5 |
|||
| MBS5756624-25mg | MyBiosource | 25mg | EUR 500 |
Ticagrelor metabolite M5 |
|||
| MBS5756624-2mg | MyBiosource | 2mg | EUR 195 |
Ticagrelor metabolite M5 |
|||
| MBS5756624-50mg | MyBiosource | 50mg | EUR 700 |
Ticagrelor metabolite M5 |
|||
| MBS5756624-5mg | MyBiosource | 5mg | EUR 235 |
Cinacalcet metabolite M4 |
|||
| MBS5752922-100mg | MyBiosource | 100mg | EUR 240 |
Cinacalcet metabolite M4 |
|||
| MBS5752922-10mg | MyBiosource | 10mg | EUR 155 |
Cinacalcet metabolite M4 |
|||
| MBS5752922-25mg | MyBiosource | 25mg | EUR 180 |
Cinacalcet metabolite M4 |
|||
| MBS5752922-50mg | MyBiosource | 50mg | EUR 210 |
Cinacalcet metabolite M4 |
|||
| MBS5752922-5mg | MyBiosource | 5mg | EUR 145 |
Ticagrelor metabolite M5 |
|||
| T21059-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Ticagrelor metabolite M5 |
|||
Ticagrelor metabolite M5 |
|||
| T21059-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Ticagrelor metabolite M5 |
|||
Ticagrelor metabolite M5 |
|||
| T21059-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Ticagrelor metabolite M5 |
|||
Ticagrelor metabolite M5 |
|||
| T21059-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Ticagrelor metabolite M5 |
|||
Ticagrelor metabolite M5 |
|||
| T21059-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Ticagrelor metabolite M5 |
|||
Lurasidone Metabolite 14283 D8 |
|||
| T19406-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Lurasidone Metabolite 14283 D8 |
|||
Lurasidone Metabolite 14283 D8 |
|||
| T19406-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Lurasidone Metabolite 14283 D8 |
|||
Lurasidone Metabolite 14283 D8 |
|||
| T19406-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Lurasidone Metabolite 14283 D8 |
|||
Lurasidone Metabolite 14283 D8 |
|||
| T19406-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Lurasidone Metabolite 14283 D8 |
|||
Lurasidone Metabolite 14283 D8 |
|||
| T19406-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Lurasidone Metabolite 14283 D8 |
|||
Lurasidone Metabolite 14326 D8 |
|||
| T19407-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Lurasidone Metabolite 14326 D8 |
|||
Lurasidone Metabolite 14326 D8 |
|||
| T19407-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Lurasidone Metabolite 14326 D8 |
|||
Lurasidone Metabolite 14326 D8 |
|||
| T19407-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Lurasidone Metabolite 14326 D8 |
|||
Lurasidone Metabolite 14326 D8 |
|||
| T19407-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Lurasidone Metabolite 14326 D8 |
|||
In addition, the separation reagent Nycodenz is non-toxic and achieved separation of primordial germ cells with out attachment of antibodies in opposition to the primordial germ cell membrane floor. This new purification methodology and stage-specific antibody will likely be helpful for the evaluation of the mechanisms of primordial germ cell migration.